News & Press Releases
For all media inquiries, please contact us.
2Morrow’s CEO, Brandon Masterson, Sits Down with Portland Seed Fund to Discuss the Current State of Digital Therapeutics.
"We’re in an exciting time in the digital therapeutics space, because it’s early days in the industry for measuring the results of behavior programs and having clinical evidence at a level that’s on par with medical devices and pharmaceutical solutions." — Brandon Masterson, 2Morrow, Inc.
Brandon explains:
"We’re in an exciting time in the digital therapeutics space, because it’s early days in the industry for measuring the results of behavior programs and having clinical evidence at a level that’s on par with medical devices and pharmaceutical solutions." — Brandon Masterson, 2Morrow, Inc.
TechCrunch: Risks and Rewards of Digital Therapeutics in Treating Mental Disorders
2Morrow is listed as an example of an emerging digital therapeutics company in an article discussing digital approaches offering great promise in overcoming the problems inherent in traditional approaches to mental and behavioral therapy. TechCrunch defines such obstacles as relating to stigma, cost, and general inaccessibility of cost-effective treatments for the general population, and states that digital therapeutic approaches offer the promise to overcome all of these problems in a highly scalable and profitable way.
2Morrow is listed as an example of an emerging digital therapeutics company in an article discussing digital approaches offering great promise in overcoming the problems inherent in traditional approaches to mental and behavioral therapy. TechCrunch defines such obstacles as relating to stigma, cost, and general inaccessibility of cost-effective treatments for the general population, and states that digital therapeutic approaches offer the promise to overcome all of these problems in a highly scalable and profitable way.
Virtual Primary Care Plus Mobile Health Pilot Shows Promising Engagement
2Morrow partnered with 98point6 to evaluate the feasibility of offering physician referred digital health programs to patients. The results of the pilot which looked at both patient enrollment and provider willingness to refer patients to the programs has been published in Telehealth and Medicine Today.
2Morrow partners with 98point6 to evaluate the feasibility of offering physician referred digital health programs to patients.
2Morrow, Inc., an evidence-based, digital health company and 98point6, an on-demand, text-based primary care service, have published the results of a collaborative pilot evaluating the feasibility of offering physician referred digital health programs (mHealth) to patients. The pilot looked at both patient enrollment and provider willingness to refer patients to the programs.
In an increasingly digitally-empowered culture, consumer expectations have changed around convenience and immediate delivery of services - including medical care. Due to its prevalence and ongoing treatment challenges in the primary care setting, there is strong interest in resources that can address the behavioral aspects of chronic disease and condition management. 2Morrow’s programs incorporate Acceptance and Commitment Therapy (ACT) skills to help patients deal with urges, emotions, and thoughts that can interfere with healthy behaviors.
During the pilot, 98point6 providers offered digital health programs via the 2Morrow Health app to patients who expressed concern about any of the following topics: tobacco addiction, chronic pain, stress/anxiety, and/or weight management. 2Morrow’s programs were recommended to a total of 28 patients, 16 of whom downloaded the app and used at least one of the programs.
"We believe this is an important proof of principle. 98point6’s nationwide service that delivers personalized consultation, diagnosis and treatment combined with the expertise in ACT provided by 2Morrow, allowed us to offer our patients access to new therapies for common health concerns," said Dr. David McCune, Medical Director of Research and Outcomes at 98point6.
Other promising insights from the pilot include:
High rate of successful follow-through (57% download and activation), particularly in light of the fact that there were several extra steps during the pilot where a patient could abandon the process.
Compliance with the recommendation to use 2Morrow in this setting suggests that physician engagement in the process of using an mHealth app can play an important role.
Over one quarter of patients who downloaded the app used more than one module suggesting that a solution that can be used for multiple health concerns is useful in this setting.
The stress and weight programs were the most utilized by patients, despite weight being the least referred program.
“2Morrow was thrilled to partner with 98point6 to explore integrating primary care and digital health programs,” said Jo Masterson, Chief Product Officer at 2Morrow. “Digital health is exploding in the consumer world, and it is encouraging to see that both healthcare providers and patients showed strong interest in behavioral focused mHealth delivered as part of their medical care. Moving forward, 2Morrow is working on tighter integrations with healthcare systems and outcome tracking to validate the usefulness of interventions for this population - results we have seen in both clinical trials and employer wellness markets.”
As more patients become accustomed to virtual healthcare options, there is a need for well-validated assessments of this trend. This project points toward both strong provider and patient interest as well as the need for research in the area of integrated digital health.
For more information, read the entire pilot manuscript “Feasibility of Recommending mHealth Solutions to Patients Receiving Virtual Primary Care”in Telehealth and Medicine Today.
2Morrow’s Chief Product Officer, Jo Masterson, is quoted in Business Insider Intelligence “What Pros Are Saying”
Asked how primary care will change over the next decade, Jo responds:
"Over the next 10 years, we will find that primary care is more triaged, often offering a digital-first experience with office visits saved for those who really need them. This will accelerate with new payment models and valued-based care." — Jo Masterson, 2morrow, Inc.
Asked how primary care will change over the next decade, Jo responds:
"Over the next 10 years, we will find that primary care is more triaged, often offering a digital-first experience with office visits saved for those who really need them. This will accelerate with new payment models and valued-based care." —Jo Masterson, 2morrow, Inc.
2Morrow is Honored to Be Named One of the 2019 Best Tech Startup’s in Kirkland, Washington by The Tech Tribune
The Tech Tribune staff has compiled the very best tech startups in Kirkland, Washington. In doing our research, we considered several factors including but not limited to: revenue potential, leadership team, brand/product traction, and competitive landscape.
"The Tech Tribune staff has compiled the very best tech startups in Kirkland, Washington. In doing our research, we considered several factors including but not limited to: revenue potential, leadership team, brand/product traction, and competitive landscape.
Additionally, all companies must be independent (un-acquired), privately owned, at most 10 years old, and have received at least one round of funding in order to qualify.”
The Top 5 Startups Disrupting Healthcare Within AI, Digital Therapeutics, Health Insurance, and Genomics by Business Insider
Startups in this report were selected based on the funding they've received over the past year, notable investors, the products they offer, and leadership in their functional area.
2Morrow is named as one of Top 5 in Digital Therapeutics.
"Startups in this report were selected based on the funding they've received over the past year, notable investors, the products they offer, and leadership in their functional area."
Nature Biotechnology
Article on Digital Therapeutics that talks about clinical trials, FDA and more. Mentions 2Morrow and quotes 2Morrow COO, Jo Masterson.
Article on Digital Therapeutics that talks about clinical trials, FDA and more. Mentions 2Morrow and quotes 2Morrow COO, Jo Masterson.
MobiHeathNews (HIMSS): In-Depth: Defining the Burgeoning Field of Digital Therapeutics
As digital and connected technologies continue to stake their claim in the industry, the last few years have seen the rise of a new type of health technology product — one that promises measurable health outcomes validated by traditional clinical trials.
As digital and connected technologies continue to stake their claim in the industry, the last few years have seen the rise of a new type of health technology product — one that promises measurable health outcomes validated by traditional clinical trials.
"Jo Masterson, cofounder and chief operating officer of 2Morrow, said that her company has a handful of clinical trials completed and another on the way for its behavioral therapy app. While her company does consider its products to be digital therapeutics and is ultimately interested in FDA, she said that 2Morrow is willing to give the process some time."
MobiHealthNews: 2Morrow Adds Chronic Pain Management to Its Mobile Behavior Therapy Offerings
Developed in collaboration with Dr. Kevin Vowles, a behavioral scientist at the University of New Mexico, 2Morrow’s program features a number of short lessons and exercises that teach users how to keep their life on track while living with chronic pain.
Much like the company’s other offerings — which target smoking, weight, and stress — the pain management program is based on acceptance and commitment therapy (ACT), a clinically tested form of cognitive behavioral therapy that’s strongly endorsed by the Society of Clinical Psychology.
Developed in collaboration with Dr. Kevin Vowles, a behavioral scientist at the University of New Mexico, 2Morrow’s program features a number of short lessons and exercises that teach users how to keep their life on track while living with chronic pain. The app-based program also allows users to message a live pain management coach if they have questions or need specific help with their condition.
2Morrow Launches New Digital Therapeutic Aimed at Managing Chronic Pain with a Non-Opioid, Behavioral Approach
2Morrow announces the release of a behavioral program targeting the 50 million Americans who live with Chronic Pain. Delivered via the 2Morrow Health’s Digital Therapeutic Platform, the program is based on an Acceptance and Commitment Therapy (ACT) approach that has proven effective for supporting chronic pain sufferers in over a dozen randomized control trials.
2Morrow teams up with UNM to take on Chronic Pain with an ACT-Based program delivered via a smartphone app.
2Morrow announces the release of a behavioral program targeting the 50 million Americans who live with Chronic Pain. Delivered via the 2Morrow Health’s Digital Therapeutic Platform, the program is based on an Acceptance and Commitment Therapy (ACT) approach that has proven effective for supporting chronic pain sufferers in over a dozen randomized control trials.
People living with persistent pain suffer greater disability, report a lower quality of life, and use more healthcare services than their pain-free counterparts. This results in a cost of over $600B to the US economy: more than cancer, heart disease or diabetes. And, with the current opioid crisis, the CDC has updated their recommendations for chronic pain treatment to include non-opioid medications, physical therapy/activity, and behavioral therapy. 2Morrow’s program offers healthcare professionals an easy, effective way to deliver the missing behavioral piece of recommended chronic pain treatment. Patients access the program via the privacy and convenience of their smartphone.
The program was developed in collaboration with Dr. Kevin Vowles from the University of New Mexico, a respected behavioral scientist who studies and treats patients with chronic pain. The development and funding of a clinical trial (in progress at UNM) was supported by a grant from the Washington State Life Sciences Discovery Fund (LSDF).
“The American Psychological Association’s Society of Clinical Psychology has given its highest rating of Strong Research Support for the clinical use of ACT with chronic pain patients” says Dr. Vowles. “2Morrow’s approach is exciting because it has the potential to extend access to people who would not otherwise have access to these behavioral concepts and skills.”
2Morrow’s program teaches people better coping skills so that they can focus more energy on their lives rather than their pain. Expected outcomes include an increase in valued activity and quality of life as well as reduction in pain-related anxiety, pain-related medical visits, and number of classes of prescribed analgesics. The program can be used to support a non-opioid treatment plan for many sufferers.
“Based on the success of our smoking cessation program, the market has asked for more programs targeting chronic conditions,” explains Jo Masterson, COO of 2Morrow. “We looked at the existing science around ACT and realized there was a huge opportunity to reduce suffering and meet a market need with Chronic Pain.” Masterson reports that 2Morrow is also working on a companion addiction module.
About 2Morrow: 2Morrow offers a digital therapeutic platform that delivers research-based programs addressing health risk behaviors and chronic conditions including smoking, weight, stress, and chronic pain. 2Morrow distributes programs through health plans, states, wellness platforms, employers, and other population health organizations. For more information about 2Morrow and the new Chronic Pain Program visit: https://www.2morrowinc.com/-chronic-pain/ @2MorrowInc @2MorrowHealth
Launch Offer: The first 200 people can get free access the the Chronic Pain program by signing up here.
GeekWire Story: 2Morrow Launches Pain Management App, as Tech Industry Addresses Opioid Crisis
Developed in collaboration with Dr. Kevin Vowles, a behavioral scientist at the University of New Mexico, 2Morrow’s program features a number of short lessons and exercises that teach users how to keep their life on track while living with chronic pain.
"Seattle startup 2Morrow Inc. on Wednesday announced the latest tech alternative for pain relief: An app that draws on behavioral psychology to help people manage chronic pain. The app uses the same scientific foundations as 2Morrow’s smoking cessation and weight loss programs."
CHR "Wellness in Your Pocket Webinar"
Over 500 people signed up for this event! Hear from two employers who share their experiences running mobile wellness programs (including 2Morrow's programs.) 60 minutes. SHRM Continuing Ed credits available for those who attended.
Over 500 people signed up for this event! Hear from two employers who share their experiences running mobile wellness programs (including 2Morrow's programs.) 60 minutes. SHRM Continuing Ed credits available for those who attended.
2Morrow Launches 2Morrow Health – Clinically-Tested Digital Health
2Morrow, known for evidence-based digital health, announces the launch of “2Morrow Health.” This platform builds on the success of 2Morrow’s SmartQuit smoking cessation app and offers research-based programs for multiple behaviors including smoking, weight and stress.
2Morrow, known for evidence-based digital health, announces the launch of “2Morrow Health.” This platform builds on the success of 2Morrow’s SmartQuit smoking cessation app and offers research-based programs for multiple behaviors including smoking, weight and stress.
Using a third-wave behavioral science approach called Acceptance and Commitment Therapy (ACT), the programs teach participants new ways to deal with the unhelpful thoughts, feelings and urges that keep them stuck in old patterns. The nonjudgmental approach, first developed at Fred Hutchinson Cancer Research Center, has already helped thousands of people quit smoking and make other desired behavioral changes. Two clinical trials have been completed and additional studies are in progress at Fred Hutch and Madigan Army Medical Center.
“Our clients are actively looking for better ways to address the exploding health costs resulting from unhealthy behaviors. They started asking for other programs “like SmartQuit” including weight and stress,” Brandon Masterson, CEO at 2Morrow. To meet this need, 2Morrow created a new platform that delivers multiple programs in one app. “Smoking cessation (SmartQuit) now joins other programs in the 2Morrow Health platform.”
2Morrow Health is a suite of research-based, behavior modification programs delivered via a smartphone app. The program is offered through wellness programs, employers, health plans and public health. 2Morrow Health includes an enterprise dashboard and api integrations for clients and an easy to use app for participants. Learn more at http://www.2morrowinc.com/2morrow-health/
Healthline Article: New Apps Help People with Addictions
Dr. Jaimee Heffner, PhD said there are a number of ways that apps can help people with addiction issues, such as those addicted to nicotine.
Dr. Jaimee Heffner, PhD said there are a number of ways that apps can help people with addiction issues, such as those addicted to nicotine. “They’re low cost, and they’re available at any time and place,” she told Healthline. “That’s generally not true for any type of treatment that is delivered by a person.”
Health Tech Podcast & Geekwire Article: Psychologists Become App Developers to Help People Kick Addictions.
Learn more about the behavioral scientists and research behind 2Morrow's Platform & SmartQuit.
Learn more about the behavioral scientists and research behind 2Morrow's Platform & SmartQuit.
Dr Bricker & Dr Heffner from Fred Hutch Cancer Research Center
2Morrow Named to Premier MedTech Accelerator
MedTech Innovator Announces Startups Selected for Industry’s Premier Accelerator
MedTech Innovator Announces Startups Selected for Industry’s Premier Accelerator.
Report: Global Digital Therapeutics Market 2017
Report: Global Digital Therapeutics Market 2017
Omada Health, WellDoc, Livongo Health, Noom Inc., 2Morrow Inc., Canary Health
Kirkland Reporter: Kirkland-Based 2Morrow Advances to Global Tech Competition
Kirkland-based 2Morrow, Inc. has won the 2017 Seattle MedTech Innovator Qualifying Round Competition for its innovative software work in behavioral change and healthy living.
Kirkland-based 2Morrow, Inc. has won the 2017 Seattle MedTech Innovator Qualifying Round Competition for its innovative software work in behavioral change and healthy living.
Jiff Partner Spotlight: Interview with SmartQuit Creator Brandon Masterson
We’ve heard that sitting is the new smoking, but that doesn’t mean smoking has become any healthier for you. Learn more about 2Morrow's solution.
We’ve heard that sitting is the new smoking, but that doesn’t mean smoking has become any healthier for you. In fact, smoking is still the leading cause of preventable death, disease, and healthcare spending in the United States. And, studies show that an average employer spends an additional $6,000 in healthcare costs and lost productivity per smoker per year. Learn more about 2Morrow's solution.
2Morrow Wins 2017 Seattle MedTech Innovator Qualifying Round Competition
2Morrow Wins 2017 Seattle MedTech Innovator Qualifying Round Competition
2Morrow Wins 2017 Seattle MedTech Innovator Qualifying Round Competition.
